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Transudative chylous pleural effusion is a very rare entity. Hereby we present a 46 year old
man a case of chronic renal failure and nephrotic syndrome with chylous ascites,
lower extremity edema and chylous transudative pleural effusion with slight response to
ultrafiltration.
ª 2008 Published by Elsevier Ltd.Introduction
Chylothorax is an infrequent cause of pleural effusion that
is most commonly caused by obstruction or disruption of
the thoracic duct. While there are many recognized etiol-
ogies of chylothorax, malignancies and trauma related to
surgical procedures account for most cases. Chylous effu-
sions are typically exudates rich in triglycerides and
chylomicrons. Nevertheless, in a small minority of patients,
the chylothorax may be transudative in nature.1 In the
sparse available literature regarding transudative chylo-
thorax, the reported etiologies are few and include
cirrhosis,2 amyloidosis,1 nephrotic syndrome,3 superior
vena caval thrombosis,4 and congestive heart failure.598 711 6474316.
s.ac.ir (M.A. Ghayumi).
lsevier Ltd.Case report
A 48 yr oldman a case of chronic renal failurewas referred to
department of pulmonology for management of dyspnea.
The patient had been diagnosed as a case of nephrotic
syndrome with ascites and lower extremity edema from 5
months ago. Patient denied cough, fever, anorexia or weight
loss. Labaratory tests showed the following: HbZ 9.6 g/dL,
MCVZ 82 mm3, WBCZ 5400/mm3, ESRZ 74 mm/h, BUNZ
18 mg/dL, CrZ 3.3 mg/dL, NaZ 135 meq/L, KZ 3.7 meq/
L, PZ 3.9 mg/dL, LDHZ 186 U/L, ASTZ 11 U/L, ALTZ
11 U/L, Alk-PhoZ 204 U/L, LipaseZ 88 U/L, AmylaseZ
73 U/L, ProteinZ 4.5 g/dL, AlbZ 1.8 g/dL, Total Bilir-
ubinZ 0.3 mg/dL, Direct BilirubinZ 0.1 mg/dL, CholZ
238 mg/dL, HDLZ 32, LDLZ 189, TGZ 84 mg/dL, ANA<
0.5, Anti Mitochondrial Antibody(IF)Z Negative, Uri-
nalysisZþ4 protein, þ3Glucose, 24 h urine for protein and
creatinine was 10 gm and 1.2 gm respectively. CXR showed
moderate right sided pleural effusion (Fig. 1) .Echocardiog-
raphy was normal.
Figure 1
32 M.A. Ghayumi et al.A diagnostic thoracentesis had revealed milky-white
fluid and hence chylothorax was suspected6 (Fig. 2). Milky
fluid was sterile on culture and negative for malignant cells
on two occasions with ProteinZ 1.1 g/dL, LDHZ 99 U/L,
SugarZ 120 mg/dL, WBCZ 75(segmentZ 65, LymphZ
10),TGZ 132 mg/dL, CholZ 19 mg/dL,, ADAZ 7.5 IU/L;
the effusion was transudative according to light criteria7
(namely pleural fluid/serum protein ratio, protein fluid/
serum LDH ratio, pleural fluid LDH concentration) and
chylous by triglyceride greater than 110 mG/dL8; hereby
establishing transudative chylous effusion. His peritonaeal
fluid analysis showed LDHZ 86 U/L, CholZ 25 mg/dL,
proteinZ 0.7 g/dL, glucoseZ 121 mg/dL,TGZ 126 mg/dL.
The patient was dyspneic and in order to reduce his
respiratory embarrassment, hemodialysis with ultrafiltra-
tion was recommended with slight beneficiary effect.
Discussion
‘‘Chylothorax’’ is the occurrence of chylous in the pleural
space, and is due to damage or blockage of the thoracic
duct. The diagnosis is made by analysis of the pleural fluid,Figure 2which contains high levels of triglycerides, and is confirmed
by the finding of chylomicrons.9 Triglyceride levels greater
than 110 mg/dL are highly suggestive of a chylous effusion.
Cholesterol values should be measured simultaneously,
since high triglyceride levels can occur in pseudochylo-
thorax,10 but the cholesterol level is always very high
(>200 mg/dL).
The causes of chylothorax may be divided into four
major categories: tumor, trauma, idiopathic, and miscel-
laneous.11 Although chyle is reported to have protein
concentrations in the transudative range, chylous effusions
are typically exudative by standard criteria.3
Transudative chylothorax is a very rare entity. Diaz-
Guzman et al.1 in a literature review had reported only 13
patients with transudative chylothorax. The etiologies were
cirrhosis, heart failure, systemic amyloidosis, superior vena
cava obstruction and nephrotic syndrome.
The conventional notion that chylothorax develops when
the thoracic duct is obstructed fails to explain events in
transudative chylothorax. Translocation of chylous ascitic
fluid across the diaphragm is the likely cause of chylothorax
in the nephrotic syndrome and in cirrhosis.12,13,14 In our
case the same laboratory characteristics of ascites and
pleural fluid supports the above mentiond hypothesis.
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